Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ASENSUS SURGICAL, INC.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ASENSUS SURGICAL, INC.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ASENSUS SURGICAL, INC.Listing unverified | Buy | $1.7M | conv 37Cluster | SEC | |
ASENSUS SURGICAL, INC.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ASENSUS SURGICAL, INC.Listing unverified | Other | $2.4M | SEC | ||
ASENSUS SURGICAL, INC.Listing unverified | BuyD (derivative) | $2.4M | ClusterFirst in 12mo | SEC | |
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | Buy | $4.4M | conv 83ClusterFirst in 12mo | SEC | |
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | Buy | $2.9M | conv 63ClusterFirst in 12mo | SEC | |
ALIMERA SCIENCES INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ALIMERA SCIENCES INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ALIMERA SCIENCES INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ALIMERA SCIENCES INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ALIMERA SCIENCES INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ALIMERA SCIENCES INCListing unverified | Buy | $1M | conv 47ClusterFirst in 12mo | SEC | |
ALIMERA SCIENCES INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |